[Pseudoneurasthenia and EEG chenges due to vitamin B 6 deficiency during INH therapy].
D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced; D000995:Antitubercular Agents / Q000009:adverse effects; D002262:Carboxy-Lyases / Q000378:metabolism; D003863:Depression / Q000139:chemically induced; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects*; D009440:Neurasthenia / Q000139:chemically induced*; D009539:Nicotinic Acids / Q000627:therapeutic use; D011736:Pyridoxine / Q000378:metabolism / Q000627:therapeutic use; D000637:Transaminases / Q000378:metabolism; D014376:Tuberculosis / Q000188:drug therapy; D026681:Vitamin B 6 Deficiency / Q000139:chemically induced*
D000995:Antitubercular Agents; D009539:Nicotinic Acids; D000637:Transaminases; D002262:Carboxy-Lyases; D011736:Pyridoxine; D007538:Isoniazid
Pseudoneurasthenie und EEG-Veränderungen durch Vitamin B 6-Mangel bei INH-Behandlung.